STOCK TITAN

Sale of 571,967 common shares planned by holder (NASDAQ: IBRX)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A shareholder has filed a Form 144 notice to sell 571,967 shares of common stock through The Charles Schwab Corporation on NASDAQ. The proposed sale has an aggregate market value of $5,909,546.00, with an approximate sale date of 01/20/2026. The filing indicates these shares were acquired from the issuer on 12/31/2013 by various methods and dates, with the full 571,967 shares acquired and paid for on that date. The table also shows that 984,965,179 shares of this class of common stock are outstanding. By signing, the seller represents they are not aware of undisclosed material adverse information about the issuer.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does this Form 144 filing related to IBRX report?

The Form 144 reports a planned sale of 571,967 shares of common stock under Rule 144, to be executed through The Charles Schwab Corporation on NASDAQ.

How many IBRX shares are planned to be sold under this Form 144?

The notice covers a proposed sale of 571,967 shares of common stock, with an aggregate market value of $5,909,546.00 based on the market data used in the form.

When is the approximate sale date for the IBRX shares in this Form 144?

The Form 144 lists an approximate date of sale of 01/20/2026 for the 571,967 common shares to be sold on NASDAQ.

How and when were the IBRX shares in this Form 144 acquired?

The filing states the 571,967 common shares were acquired from the issuer on 12/31/2013 by various methods & dates, with the amount of securities acquired and the date of payment both shown as 12/31/2013.

How many IBRX common shares are outstanding according to this Form 144?

The securities information table reports that there are 984,965,179 shares of this class of common stock outstanding at the time referenced in the form.

What representation does the selling shareholder make in this Form 144?

By signing, the person for whose account the securities are to be sold represents that they do not know any material adverse information about the issuer's current or prospective operations that has not been publicly disclosed.

Immunitybio Inc

NASDAQ:IBRX

IBRX Rankings

IBRX Latest News

IBRX Latest SEC Filings

IBRX Stock Data

7.23B
330.74M
69.2%
13.26%
7.97%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
SAN DIEGO